Meeting Banner
Abstract #3182

Preoperative Differentiation Between Grade II and III Gliomas Subtypes and Genotypes Using MR Spectroscopy, Perfusion and Diffusion Imaging

Slim Fellah1, Delphine Caudal2, Philippe Dory-Lautrec2, Patrick Viout1, Olivier Chinot3, Philippe Metellus4, Dominique Figarella-Branger5, Virginie Callot1, Patrick J.

1CRMBM, CNRS, Aix-Marseille Univ, Marseille, France; 2Department of Neuroradiology, APHM, Hopital de la Timone, Marseille, France; 3Department of Neurooncology, APHM, Hopital de la Timone, Marseille, France; 4Department of Neurosurgery, APHM, Hopital de la Timone, Marseille, France; 5Department of Phathology and Neuropathology, APHM, Hopital de la Timone, Marseille, France

Preoperative diagnosis of gliomas is challenging and clinically important for therapy planning. Conventional MRI provides valuable information for the preoperative diagnosis of brain tumors but still insufficient in some cases. Moreover, patients with 1p/19q codeletion and/or IDH1 mutation have longer survival than those possessing the wild type. We used a multimodal MRI protocol including diffusion, perfusion and spectroscopy to investigate noninvasively patients with WHO grade II and III oligodendrogliomas and oligoastrocytomas. Our findings helped differentiating these tumors according to their subtypes but also according to their molecular status. This could be helpful for designing customized therapies and for patient management.

Abstract PDF E-Poster Video

Keywords

ability according adult analyses apparent array attenuated blood brain cerebral channel classification classifying clinically coded coefficient coil combination combining complete considered considering consisted contrast corrected correlated dean decision designing determined developed diagnosis differentiate differentiating differentiation diffusion discriminant dory enhancement establishing exams flair flow fluid forty free frontal gene genes genotype genotypes goal gold grade grades grading head help helped helpful hemorrhage heterogeneous important included independently index insular intact investigate localization location long longer management materials medical metabolite misleading modalities molecular moreover mostly mutation necrosis neurology neuropathology neurosurgery normalizing nowadays others overall patient patients perfusion permeability possessing post preoperative processing progression protocol proton proven providing quantification radiology really recovery representative respectively samples sampling scanner schema score selected sensibility separated separation sequencing short significantly slim software softwares specificity spectroscopic spectroscopy status still subgroups subtype subtypes sure surgical survival susceptibility symphony table tailored therapies therapy tissue treatment tumor tumors type valuable variations walker years